Neil Kumar's Net Worth
$164 Million
Who is Neil Kumar?
Neil Kumar has an estimated net worth of $164 Million. This is based on reported shares across multiple companies, which include BridgeBio Pharma, Inc., LianBio, and Eidos Therapeutics, Inc..
SEC CIK
Neil Kumar's CIK is 0001742485
Past Insider Trading and Trends
2021 was Neil Kumar's most active year for acquiring shares with 8 total transactions. Neil Kumar's most active month to acquire stocks was the month of January. 2023 was Neil Kumar's most active year for disposing of shares, totalling 24 transactions. Neil Kumar's most active month to dispose stocks was the month of July. 2021 saw Neil Kumar paying a total of $1,000,000.00 for 1,094,048 shares, this is the most they've acquired in one year. In 2024 Neil Kumar cashed out on 352,660 shares for a total of $4,100,662.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$24.64 | -$1,363,067.25 | 14.72M |
Aug 16 - Aug 19
| |||
Form 4
| +0.61% | 29.92K |
$31.04 | -$954,417.92 | 4.9M |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +1.13% | 54.33K |
$37.21 | -$1,783,177.62 | 4.87M |
Feb 16
| |||
Form 4
|
—
|
0
|
$28.98 | -$2,963,152.94 | 4.81M |
Scheduled
|
Nov 16 - Nov 17
| ||
Form 4
|
—
|
0
|
$29.19 | -$2,984,584.44 | 4.81M |
Aug 16 - Aug 17
| |||
Form 4
|
—
|
0
|
$14.05 | -$1,436,538.47 | 4.81M |
May 16 - May 17
| |||
Form 4
| -10.59% | -120.00K |
$14.18 | -$1,701,744.00 | 1.01M |
May 3
| |||
Form 4
| -9.58% | -120.00K |
$15.46 | -$1,855,656.00 | 1.13M |
Apr 5
| |||
Form 4
| -8.74% | -120.00K |
$10.96 | -$1,315,224.00 | 1.25M |
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$12.68 | -$871,270.59 | 4.81M |
Scheduled
|
Feb 16 - Feb 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| -8.04% | -120.00K |
$11.01 | -$1,320,696.00 | 1.37M |
Scheduled
|
Feb 3
| ||
Form 4
| -7.44% | -120.00K |
$7.67 | -$920,856.00 | 1.49M |
Scheduled
|
Jan 5
| ||
Form 4
| -16.73% | -200.00K |
—
|
—
| 1M |
Dec 21
| |||
Form 4
|
—
|
0
|
$9.52 | -$654,001.85 | 4.81M |
Nov 16 - Nov 17
| |||
Form 4
| +0.86% | 41.01K |
$11.08 | -$306,882.76 | 4.81M |
Aug 16
| |||
Form 4
| +0.95% | 44.95K |
$6.74 | -$160,135.66 | 4.77M |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
| +0.09% | 4.44K |
$8.84 | -$27,271.40 | 4.73M |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
| +0.08% | 3.79K |
$47.25 | -$176,242.50 | 4.72M |
Nov 16
| |||
Form 4
| +0.08% | 3.79K |
$49.48 | -$184,560.40 | 4.72M |
Aug 16
| |||
Form 4
| +0.08% | 3.79K |
$53.66 | -$200,205.46 | 4.72M |
May 16
| |||
Form 4
| +0.40% | 18.99K |
$63.74 | -$138,992.22 | 4.71M |
Feb 16 - Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +0.07% | 3.35K |
$44.33 | -$78,641.42 | 4.69M |
Nov 16
| |||
Form 4
| +0.07% | 3.35K |
$28.53 | -$50,612.22 | 4.69M |
Aug 16
| |||
Form 4
| -3.69% | -80.00K |
$27.23 | -$2,178,066.07 | 2.09M |
Scheduled
|
Aug 3 - Aug 4
| ||
Form 4
| -6.21% | -143.47K |
$30.75 | -$4,411,357.06 | 2.17M |
Scheduled
|
Jul 1 - Jul 2
| ||
Form 4
| -0.46% | -10.60K |
$30.01 | -$318,125.08 | 2.31M |
Scheduled
|
Jun 8
| ||
Form 4
| -0.26% | -5.93K |
$30.05 | -$178,173.37 | 2.32M |
Scheduled
|
Jun 3
| ||
Form 4
| -3.33% | -80.00K |
$29.19 | -$2,335,389.61 | 2.33M |
Scheduled
|
Jun 1
| ||
Form 4
| -3.20% | -79.60K |
$31.02 | -$2,469,481.93 | 2.41M |
Scheduled
|
May 5
| ||
Form 4
| -3.13% | -80.40K |
$29.40 | -$2,364,085.00 | 2.48M |
Scheduled
|
May 1 - May 4
| ||
Form 4
| -0.07% | -1.80K |
$25.48 | -$45,983.10 | 2.57M |
Scheduled
|
Apr 7
| ||
Form 4
| -0.01% | -300.00 |
$25.09 | -$7,528.00 | 2.57M |
Scheduled
|
Apr 3
| ||
Form 4
| -2.94% | -77.89K |
$26.02 | -$2,026,465.64 | 2.57M |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| -4.34% | -120.00K |
$32.28 | -$3,874,030.43 | 2.65M |
Scheduled
|
Mar 2 - Mar 3
| ||
Form 4
| -1.10% | -30.89K |
$34.87 | -$1,077,390.29 | 2.77M |
Scheduled
|
Feb 5
| ||
Form 4
| -3.09% | -89.11K |
$34.70 | -$3,091,609.79 | 2.8M |
Scheduled
|
Feb 3 - Feb 4
| ||
Form 4
| -3.99% | -120.00K |
$32.52 | -$3,902,416.96 | 2.89M |
Scheduled
|
Jan 2 - Jan 3
| ||
Form 4
|
∞
| 8.95M |
—
|
—
| 8.95M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LianBio (LIAN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eidos Therapeutics, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.72% | 882.35K |
$29.90 | $26,382,795.88 | 24.58M |
Jul 3
| |||
Form 4
| +4.89% | 1.1M |
$25.93 | $28,622,778.64 | 23.69M |
May 24
| |||
Form 4
|
∞
| 19.61M |
$17.00 | $13,400,046.00 | 19.61M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||